Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

UnitedHealth Group Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Medical costs payable	39,337)	40,181)	38,427)	37,136)	34,224)	33,951)	32,547)	34,032)	32,395)	32,792)	31,947)	31,809)	29,056)	29,064)	28,978)	28,676)	24,483)	25,918)	25,131)	24,833)
Accounts payable and accrued liabilities	38,032)	36,033)	34,330)	33,566)	34,337)	33,080)	30,886)	30,738)	31,958)	31,164)	29,516)	29,856)	27,715)	27,232)	25,145)	25,058)	24,643)	24,292)	23,013)	22,997)
Short-term borrowings and current maturities of long-term debt	6,069)	7,737)	5,698)	9,986)	4,545)	3,909)	11,371)	9,787)	4,274)	5,290)	6,321)	9,931)	3,110)	3,229)	5,592)	6,697)	3,620)	3,620)	3,868)	8,838)
Unearned revenues	3,413)	3,366)	3,032)	3,296)	3,317)	3,320)	2,572)	3,206)	3,355)	15,311)	14,852)	14,487)	3,075)	12,847)	2,212)	2,675)	2,571)	2,556)	2,365)	2,612)
Other current liabilities	28,046)	28,209)	29,294)	29,487)	27,346)	27,305)	27,294)	26,668)	27,072)	29,622)	30,345)	30,399)	26,281)	28,563)	26,771)	25,064)	22,975)	23,189)	22,180)	21,361)
Current liabilities	114,897)	115,526)	110,781)	113,471)	103,769)	101,565)	104,670)	104,431)	99,054)	114,179)	112,981)	116,482)	89,237)	100,935)	88,698)	88,170)	78,292)	79,575)	76,557)	80,641)
Long-term debt, less current maturities	72,320)	72,399)	73,495)	71,285)	72,359)	74,101)	63,727)	63,850)	58,263)	58,079)	59,268)	60,657)	54,513)	45,438)	45,799)	40,796)	42,383)	43,345)	44,348)	37,420)
Deferred income taxes	2,421)	3,162)	3,804)	3,902)	3,620)	4,014)	3,631)	4,167)	3,021)	2,210)	2,498)	2,834)	2,769)	1,659)	2,581)	2,954)	3,265)	3,649)	3,641)	3,602)
Other liabilities	18,245)	18,369)	15,709)	15,963)	15,939)	15,174)	14,794)	14,844)	14,463)	13,615)	13,261)	13,084)	12,839)	12,111)	11,967)	11,671)	11,787)	11,844)	12,425)	12,926)
Noncurrent liabilities	92,986)	93,930)	93,008)	91,150)	91,918)	93,289)	82,152)	82,861)	75,747)	73,904)	75,027)	76,575)	70,121)	59,208)	60,347)	55,421)	57,435)	58,838)	60,414)	53,948)
Total liabilities	207,883)	209,456)	203,789)	204,621)	195,687)	194,854)	186,822)	187,292)	174,801)	188,083)	188,008)	193,057)	159,358)	160,143)	149,045)	143,591)	135,727)	138,413)	136,971)	134,589)
Redeemable noncontrolling interests	1,608)	4,244)	4,315)	4,358)	4,323)	4,574)	4,558)	4,548)	4,498)	4,416)	4,788)	4,801)	4,897)	4,857)	4,922)	1,519)	1,434)	1,373)	1,299)	1,269)
Preferred stock, $0.001 par value; no shares issued or outstanding	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Common stock, $0.01 par value	9)	9)	9)	9)	9)	9)	9)	9)	9)	9)	9)	9)	9)	10)	10)	10)	10)	10)	10)	10)
Additional paid-in capital	559)	394)	—)	—)	—)	461)	373)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Retained earnings	95,603)	97,595)	97,250)	97,934)	96,036)	96,518)	92,400)	90,118)	95,774)	93,173)	89,994)	88,852)	86,156)	83,722)	80,540)	78,782)	77,134)	75,124)	73,090)	71,220)
Accumulated other comprehensive loss	(2,061)	(2,211)	(2,535)	(2,905)	(3,387)	(2,453)	(3,423)	(3,439)	(7,027)	(8,688)	(7,650)	(7,549)	(8,393)	(9,086)	(7,730)	(6,026)	(5,384)	(4,856)	(4,086)	(4,826)
Shareholders’ equity attributable to UnitedHealth Group	94,110)	95,787)	94,724)	95,038)	92,658)	94,535)	89,359)	86,688)	88,756)	84,494)	82,353)	81,312)	77,772)	74,646)	72,820)	72,766)	71,760)	70,278)	69,014)	66,404)
Nonredeemable noncontrolling interests	5,980)	5,782)	5,745)	5,773)	5,610)	5,346)	5,317)	5,682)	5,665)	5,070)	5,015)	4,509)	3,678)	3,418)	3,385)	3,362)	3,285)	2,981)	3,008)	2,909)
Total equity	100,090)	101,569)	100,469)	100,811)	98,268)	99,881)	94,676)	92,370)	94,421)	89,564)	87,368)	85,821)	81,450)	78,064)	76,205)	76,128)	75,045)	73,259)	72,022)	69,313)
Total liabilities, redeemable noncontrolling interests and equity	309,581)	315,269)	308,573)	309,790)	298,278)	299,309)	286,056)	284,210)	273,720)	282,063)	280,164)	283,679)	245,705)	243,064)	230,172)	221,238)	212,206)	213,045)	210,292)	205,171)

Overall, the balance sheet reveals a generally increasing trend in both total liabilities and total stockholders’ equity over the observed period, from March 31, 2021, through December 31, 2025. While fluctuations occur, the company demonstrates consistent growth in its financial obligations and ownership stake. A significant increase in current liabilities is observed in late 2022 and continues into 2023, followed by a stabilization and slight decrease in later periods. Long-term debt also exhibits variability, with notable increases in 2022 and 2024.

Current Liabilities: Current liabilities generally increased from $80.641 billion in March 2021 to a peak of $116.482 billion in March 2023. A subsequent decline to $104.431 billion in March 2024 was observed, followed by a slight increase to $114.897 billion by December 2025. Within current liabilities, medical costs payable consistently represent a substantial portion, increasing from $24.833 billion to $40.181 billion over the period. Accounts payable and accrued liabilities also show a steady upward trend, rising from $22.997 billion to $38.032 billion. Short-term borrowings demonstrate more volatility, peaking at $9.931 billion in March 2023 before decreasing to $6.069 billion by December 2025. Unearned revenues experienced a substantial increase in September 2022, reaching $12.847 billion, before returning to more moderate levels between $3.032 billion and $3.413 billion in subsequent periods. Other current liabilities also increased steadily throughout the period.
Long-Term Debt and Noncurrent Liabilities: Long-term debt, less current maturities, fluctuated considerably. It began at $37.420 billion in March 2021, increased to $54.513 billion by December 2022, and then settled around $72.320 billion by December 2025. Deferred income taxes remained relatively stable, generally between $2.210 billion and $4.167 billion. Other liabilities also exhibited a gradual increase, moving from $12.926 billion to $18.245 billion. The combined effect of these components resulted in noncurrent liabilities increasing from $53.948 billion in March 2021 to $92.986 billion by December 2025.
Stockholders’ Equity: Total stockholders’ equity demonstrated consistent growth, increasing from $69.313 billion in March 2021 to $100.090 billion by December 2025. Retained earnings were the primary driver of this growth, rising from $71.220 billion to $95.603 billion. Accumulated other comprehensive loss remained negative throughout the period, fluctuating between -$8.688 billion and -$2.061 billion. Redeemable noncontrolling interests showed a moderate increase, from $1.269 billion to $1.608 billion, while nonredeemable noncontrolling interests increased from $2.909 billion to $5.980 billion. Additional paid-in capital saw a significant increase in June 2024, reaching $373 million, and again in September 2024, reaching $394 million.

The overall trend indicates a company experiencing growth in both its financial obligations and its equity base. The fluctuations in short-term borrowings and unearned revenues suggest active management of working capital. The increase in long-term debt indicates strategic investment or financing activities. The consistent growth in retained earnings reflects profitability and effective capital allocation.

AI Ask an analyst for more

Download chart

UnitedHealth Group Inc. (NYSE:UNH)

Balance Sheet: Liabilities and Stockholders’ EquityQuarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data